Systemic Lupus |
|
|
Recent Blog Posts
View Post: Lupus And Employment
16 hours ago by Angela Odom
According to UC study, unemployment in patients with systemic lupus erythematosus (SLE) may be related to them not starting work at all, rather than losing their jobs as their condition progresses. Taking data from the Census Bureau and ...
View Blog: FemmeNoir - http://femmenoir.net/
View Post: Medicrit - Medicare: The Complexity of Systemic Lupus Erythematosus
4 Nov 2009 by Healthy Life
Systemic lupus erythematosus is a life-threatening chronic autoimmune disease. Although the mortality rate of patients with systemic lupus erythematosus has reduced in the last decades, the disease continues to raise serious problems to ...
View Blog: Medicrit - Medicare - http://www.medicrit.org/
View Post: Molecular mimicry in systemic lupus erythematosus -- Agmon-Levin ...
30 Oct 2009 by Agmon-Levin, N., Blank, M., Paz, Z., Shoenfeld, Y.
Systemic lupus erythematosus is a multi-systemic autoimmune disease distinguished by the presence of various autoantibodies. Like most autoimmune diseases, systemic lupus erythematosus is believed to be induced by a combination of ...
View Blog: Lupus current issue - http://lup.sagepub.com/
View Post: Myeloid leukaemia in systemic lupus erythematosus–a nested case ...
10 Nov 2009 by rob
Myeloid leukaemia in systemic lupus erythematosus–a nested case-control study based on Swedish registers. Rheumatology (Oxford). 2009 Oct;48(10):1222-6. Authors: Löfström B, Backlin C, Sundström C, Hellström-Lindberg E, Ekbom A, ...
View Blog: CMLHope.Com - http://cmlhope.com/
View Post: ImmuPharma PLC: Encouraging Final Phase IIb Results Seen With ...
19 Nov 2009 by DrugsNews
ImmuPharma PLC (LSE:IMM) the specialist discovery and development pharmaceutical company is pleased to announce the final results from a Phase IIb trial of LUPUZOR™ in active patients with Systemic Lupus Erythematosus (SLE). ...
View Blog: Drugs Reviews
View Post: ImmuPharma PLC: Encouraging Final Phase IIb Results Seen with ...
19 Nov 2009 by Maureen Martino
LONDON--(BUSINESS WIRE)--ImmuPharma PLC (LSE:IMM) the specialist discovery and development pharmaceutical company is pleased to announce today the final results from a Phase IIb trial of LUPUZORTM in active patients with Systemic Lupus ...
View Blog: Press Releases - http://www.fiercebiotech.com/press-releases
View Post: pubget—the blog: Hot off the presses! Nov 01 Nature medicine
4 hours ago by ian connor
This increases autoantibody production and predisposes global and macrophage-specific Ppard-/- mice to autoimmune kidney disease, a phenotype resembling the human disease systemic lupus erythematosus. Thus, PPAR- has a pivotal role in ...
View Blog: pubget—the blog - http://pubget.blogspot.com/

Not Signed In -

